Clinical Trial Update: Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the efficacy and safety of perampanel for refractory status epilepticus was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Status Epilepticus

Drugs mentioned

• Fycompa (perampanel)

Snippet

Sponsor: Wayne State University | Conditions: Refractory Status Epilepticus | Phase 4 | Status: TERMINATED